Keep informed about the latest topics in global health.
#VaccinesWork
FOCUS AREAS African Vaccine Manufacturing Accelerator (AVMA) Zero-Dose Child Gavi Secretariat and leadership Progress report Partners Our Board
CAREERS Current vacancies Internship programme RFPs and consulting
Contact us ISO certification Phishing and fraud
SUPPORTED COUNTRIESDetailed information on each Gavi-eligible countryExplore our Country Hub
FOR COUNTRIES
Apply for support
Gavi 5.0 Ceilings by country and support type
OUR RESULTS
Evaluation studies
Facts and figures
Progress reports
COVID-19
The Global Vaccine Impact Conference explained
Read article
KEY AREAS
Donor profiles
Matching Fund
Pneumococcal AMC
FEATURED STORY
Everything you need to know about Gavi's incoming CEO, Dr Sania Nishtar
KEY PUBLICATION
The 2023 Mid-Term Review Report
PROGRESS REPORT
18 April 2016
Summary HSS Evaluation Yemen
Tajikistan HSS Evaluation Report
Yemen HSS Evaluation Report
10 March 2016
Second annual Full Country Evaluations report (2014) – Gavi response
26 February 2016
Pneumococcal AMC impact evaluation Gavi management response
Pneumococcal AMC outcomes and impact evaluation
Pneumococcal AMC outcomes and impact evaluation - Summary
20 July 2015
Findings from the 2014 Gavi Full Country Evaluation - Bangladesh
Findings from the 2014 Gavi Full Country Evaluation - Mozambique
Findings from the 2014 Gavi Full Country Evaluation - Uganda
Findings from the 2014 Gavi Full Country Evaluation - Zambia
Gavi Full Country Evaluation 2014 Annual Dissemination Report